Drug Approval | June 26, 2024
USDA approves Merck Animal Health’s NOBIVAC NXT canine flu H3N2
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease
The facility was inspected from May 7 to May 17, 2024
This tie-up will have no impact on any other brands of the company
GL0034 administered once-weekly confirmed clinically meaningful weight loss and improved glucometabolic parameters over a 4-week treatment period in individuals with obesity
Combined entity is better positioned to compete in increasingly competitive generics industry
Renews GMP certifications for India and Malaysia sites
The Issue opened on June 18, 2024 and closed on June 21, 2024
The company will now explore a buyer for its manufacturing site and exit in due course
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
DSP-5336, an Investigational Menin and Mixed-lineage Leukemia Inhibitor, is Being Evaluated in Patients with Relapsed or Refractory Acute Leukemia
Subscribe To Our Newsletter & Stay Updated
